United Malacca Bhd (2593)
Bursa Malaysia · Malaysia · prices in MYR · close of 27 Oct 2026
Key indicators
| Last close | MYR 6.060 |
|---|---|
| 52-week range | 5.600 – 6.130 |
| Return, 1 month / 3 months | +1.8% / +2.7% |
| Return, 1 year / 3 years | +7.2% / +27.7% |
| Trend | Uptrend |
| RSI (14) | 55 |
| Volatility (1 year) | 11.5% |
| Worst drawdown (1 year) | -3.7% |
| Average daily value traded | 0.20M MYR |
| Dividend yield | 2.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
United Malacca Berhad is a Malaysian plantation company based in Melaka that cultivates oil palm and produces crude palm oil and palm kernel. It manages estates and palm oil mills, and its operations extend to Indonesia as well as Malaysia. The company's customers are the processors, refiners and traders that use its palm products, and it has also been involved in rubber cultivation. Its business centres on the growing, harvesting and initial processing of agricultural crops.
On this site United Malacca Bhd appears as a stock on the Bursa Malaysia (Malaysia), code 2593, with prices in Malaysian ringgit (MYR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
United Malacca Bhd (2593) trades on the Bursa Malaysia in Malaysia. It last closed at MYR 6.060 on 27 October 2026.
Its price-based Market X-Ray is 75 out of 100 (a strong price profile), ranking 93 of 1,066 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 7.2% and over the last three months it rose 2.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Bursa Malaysia
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 80 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 3.5% | ||
| From 52-week high | -1.1% | ||
| Momentum | 70 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 2.7% | ||
| 6-month return | 3.0% | ||
| 12-month return, skipping the last month | 5.2% | ||
| Stability (higher is calmer) | 99 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 11.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -3.7% | ||
| Liquidity | 59 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.20M MYR | ||
| Zero-volume days | 6.7% | ||
| Income | 45 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.3% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.3% |
|---|---|
| 1 month | +1.8% |
| 3 months | +2.7% |
| 6 months | +3.0% |
| 1 year | +7.2% |
| 3 years | +27.7% |
| 5 years | +29.8% |
Signals
| 50-day / 200-day average | 5.992 / 5.857 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.041 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 Jul 2026 | MYR 0.0700 |
| 19 Jan 2026 | MYR 0.0700 |
| 24 Jul 2025 | MYR 0.0600 |
| 9 Dec 2024 | MYR 0.0500 |
| 29 Jul 2024 | MYR 0.0700 |
| 18 Jan 2024 | MYR 0.0500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Bursa Malaysia; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.